跳至主要内容
临床试验/NCT00227214
NCT00227214已完成不适用

Prevalence of Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.

Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 160 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160

研究概览

简要总结

The aim of this study is to determine the prevalence of pneumococcal meningitis in the paediatric population in Spain four years after the marketing of Prevenar. Also secondary objectives are: 1) to determine the clinical characteristics and outcome of the disease; and 2) to determine serotypes and antibiotic resistance patterns.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • All children from 0 up to 14 years with diagnosis of confirmed or probable pneumococcal meningitis or with diagnosis of suspected bacterial meningitis without bacterial or viral isolation will be included into the study.

排除标准

  • 未提供

研究者

发起方
Wyeth is now a wholly owned subsidiary of Pfizer
申办方类型
Industry

相似试验